Rosali Moellmann
QA Manager, Combination Products and responsible for Risk Management within development
Bayer AG
- Dr. Rosali Möllmann, QA Manager for combination products and responsible for Risk Management within development at Bayer Pharma
- Joined Bayer from B.Braun in 2020 where she was a Project lead for Combination Product Development (class 3 devices)
- Has 15 years of experience in development (12 years in Pharma/MD industrie)
- Engineer by education
- Understands Risk Management as a continuous and holistic task to ensure patient safety and product effectiveness